Activation of Nrf2 Pathways Correlates With Resistance of NSCLC Cell Lines to CBP501 in Vitro
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0808
Full Text
Open PDFAbstract
Available in full text
Date
July 22, 2014
Authors
Publisher
American Association for Cancer Research (AACR)